Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Vincent Colicchio maintains an Outperform rating on Concentrix (NASDAQ:CNXC) but lowers the price target from $121 to $84.

March 27, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Concentrix's Outperform rating is maintained by Barrington Research, though its price target has been reduced from $121 to $84.
The maintenance of an Outperform rating suggests a positive outlook on Concentrix's performance, despite the significant reduction in price target. This mixed signal could lead to neutral short-term price movement as investors weigh the lowered expectations against the analyst's continued confidence in the company's prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100